blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2099804

EP2099804 - COMPOUNDS FOR THE TREATMENT OF HEPATITIS C [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.01.2018
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  17.02.2017
FormerGrant of patent is intended
Status updated on  07.11.2016
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): CY		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[2017/12]
Former [2009/38]For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton NJ 08543-4000 / US
Inventor(s)01 / BENDER, John, A.
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492 / US
02 / DING, Min
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492 / US
03 / GENTLES, Robert, G.
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492 / US
 [2017/12]
Former [2009/38]01 / BENDER, John, A.
c/o Bristol-Myers Squibb Company 5 Research Parkway
Wallingford, Connecticut 06492 / US
02 / DING, Min
c/o Bristol-Myers Squibb Company 5 Research Parkway
Wallingford, Connecticut 06492 / US
03 / GENTLES, Robert, G.
c/o Bristol-Myers Squibb Company 5 Research Parkway
Wallingford, Connecticut 06492 / US
Representative(s)Reitstötter Kinzebach
Patentanwälte
Sternwartstraße 4
81679 München / DE
[N/P]
Former [2017/12]Reitstötter Kinzebach
Patentanwälte
Sternwartstrasse 4
81679 München / DE
Former [2009/38]Reitstötter - Kinzebach
Patentanwälte Sternwartstrasse 4
81679 München / DE
Application number, filing date08727516.010.01.2008
[2009/38]
WO2008US50715
Priority number, dateUS20070884459P11.01.2007         Original published format: US 884459 P
[2009/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008089027
Date:24.07.2008
Language:EN
[2008/30]
Type: A1 Application with search report 
No.:EP2099804
Date:16.09.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 24.07.2008 takes the place of the publication of the European patent application.
[2009/38]
Type: B1 Patent specification 
No.:EP2099804
Date:22.03.2017
Language:EN
[2017/12]
Search report(s)International search report - published on:EP24.07.2008
ClassificationIPC:C07D487/08, A61K31/4995, A61P1/16, A61P31/14
[2009/38]
CPC:
C07D487/08 (EP,US); A61P1/16 (EP); A61P31/00 (EP);
A61P31/12 (EP); A61P31/14 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/12]
Former [2009/38]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERBINDUNGEN ZUR BEHANDLUNG VON HEPATITIS C[2009/38]
English:COMPOUNDS FOR THE TREATMENT OF HEPATITIS C[2009/38]
French:COMPOSÉS POUR LE TRAITEMENT DE L'HÉPATITE C[2009/38]
Entry into regional phase07.07.2009National basic fee paid 
07.07.2009Designation fee(s) paid 
07.07.2009Examination fee paid 
Examination procedure07.07.2009Examination requested  [2009/38]
12.04.2011Despatch of a communication from the examining division (Time limit: M04)
29.07.2011Reply to a communication from the examining division
08.11.2016Communication of intention to grant the patent
09.02.2017Fee for grant paid
09.02.2017Fee for publishing/printing paid
09.02.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.04.2011
Opposition(s)02.01.2018No opposition filed within time limit [2018/09]
Fees paidRenewal fee
13.01.2010Renewal fee patent year 03
14.01.2011Renewal fee patent year 04
11.01.2012Renewal fee patent year 05
10.01.2013Renewal fee patent year 06
21.01.2014Renewal fee patent year 07
13.01.2015Renewal fee patent year 08
11.01.2016Renewal fee patent year 09
11.01.2017Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.01.2008
AT22.03.2017
CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
TR22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
[2020/31]
Former [2020/28]HU10.01.2008
AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
TR22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2020/15]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
TR22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2019/30]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/14]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
IT22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/09]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2017/51]AT22.03.2017
CZ22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2017/50]AT22.03.2017
CZ22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
Former [2017/49]AT22.03.2017
CZ22.03.2017
EE22.03.2017
ES22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
RO22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
Former [2017/48]CZ22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
SE22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
Former [2017/41]FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
SE22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
Cited inInternational search[X]WO2006020082  (BRISTOL MYERS SQUIBB CO [US], et al) [X] 1-13* claims 12,13,16 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.